Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00015041 · ClinicalTrials.gov registry record · Phase 1
Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2
A Phase 1 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 1
- Development phase
NCT00015041 is a Phase 1 study that has completed, run by National Institute on Drug Abuse (NIDA).
The verdict
NCT00015041, a Phase 1 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
The purpose of this study is to evaluate the effect, pharmacokinetics and dose proportionality of buprenorphine when administered to non-dependent opiate users. 1) To evaluate whether plasma concentrations of buprenorphine increase proportionally to buprenorphine dose. 2) To evaluate the dose-response of subjective and physiological effects of buprenorphine; and 3) To determine the safety of buprenorphine.
Interventions
- DRUG Buprenorphine
Trial Details
| Field | Value |
|---|---|
| Start Date | 1996-11 |
| Est. Completion | 1998-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00015041
The ClinicalTrials.gov registry entry for NCT00015041 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Buprenorphine is the first listed.
NCT00015041 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00015041 about?
NCT00015041 is a clinical study titled "Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2". The purpose of this study is to evaluate the effect, pharmacokinetics and dose proportionality of buprenorphine when administered to non-dependent opiate users. 1) To evaluate whether plasma concentrations of buprenorphine increase proportionally to buprenorphine dose. 2) To evaluate the dose-respon...
What is the current status of trial NCT00015041?
This trial is currently completed. It is a Phase 1 study. The study started on 1996-11. Estimated completion is 1998-07.
What interventions are being tested in trial NCT00015041?
The interventions under investigation include: Buprenorphine (DRUG).
Who is sponsoring clinical trial NCT00015041?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.